Experts Sound Alarm as Avian Flu Spreads Among Cats
“[A vaccine prototype] should go through Phase I and II clinical trials against the strain that is very likely to start transmitting not just between animals, but from human to human,” Gintsburg stated in an interview aired on Wednesday.
The institute, which developed Sputnik V—the first registered Covid-19 vaccine—has now turned its attention to the evolving threat.
Gintsburg cautioned that a mutation of the virus enabling airborne human-to-human transmission could lead to a crisis even worse than smallpox.
“The fatality rate is 50–70%, and if transmitted by air, smallpox will seem like child’s play compared to what could happen after one or two mutations,” he warned.
Gintsburg stressed the need for Russia to develop the vaccine quickly.
“A ready prototype should be available to scale up production in three to four weeks and introduce it for public use,” he added, noting that no such program is currently in place.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
